Basel Medical Group Ltd Ordinary Shares
Quarterly Financials
| Values in thousands | 2026-03-31 | 2025-09-30 |
|---|---|---|
Revenue | $8,239 | $6,054 |
Gross Profit | -983 | 644 |
EBITDA | -860 | -815 |
EBIT | -2,911 | -1,614 |
Net Income | 268 | -9,939 |
Net Change In Cash | 8,239 | 6,054 |
Free Cash Flow | -1,753 | -821 |
Cash | 1,342 | 2,979 |
Basic Shares | 1,565 | 18,785 |
Annual Financials
| Values in thousands | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 |
|---|---|---|---|---|
Revenue | $11,319 | $10,050 | $9,701 | $10,658 |
Gross Profit | 8,793 | 7,802 | 7,364 | 8,479 |
EBITDA | -11,120 | 3,109 | 2,927 | 3,283 |
EBIT | -12,301 | 2,580 | 2,370 | 2,707 |
Net Income | -12,087 | 2,072 | 1,783 | 1,977 |
Net Change In Cash | 11,319 | 10,050 | 9,701 | 10,658 |
Free Cash Flow | -4,398 | 2,501 | 2,593 | 2,703 |
Cash | 2,979 | 1,951 | 1,217 | 1,563 |
Basic Shares | 1,565 | 1,354 | 1,354 | 1,354 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-09-30 | -$0.55 |
2025-03-31 | -$0.02 |
2024-09-30 | $0.05 |